Outset Medical, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Outset Medical has released its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.
NASDAQ
Outset Medical announces the appointment of Kevin OBoyle to its Board of Directors and the resignation of Dale Jones, effective May 14, 2025.
NASDAQ
DEFA14A: Outset Medical, Inc. Sets Date for 2025 Annual Meeting, Outlines Proposals for Stockholder Vote
Outset Medical, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on June 2, 2025, with key proposals including the election of directors, executive compensation approval, and amendments to equity incentive and employee stock purchase plans.
NASDAQ
Outset Medical is asking stockholders to approve amendments to its equity incentive and employee stock purchase plans at the 2025 annual meeting to increase the number of shares available for issuance.
NASDAQ
Outset Medical is holding a special meeting to seek stockholder approval for a share issuance related to a recent financing, a reverse stock split, and other related proposals.
NASDAQ
Outset Medical, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on May 29, 2024, with voting open until May 28, 2024.
NASDAQ
Outset Medical's 2024 proxy statement outlines proposals for director elections, executive compensation approval, and auditor ratification, alongside details on corporate governance and executive pay.